Vetoquinol SA (LON:0O1O)

Market Cap	716.10M
Revenue (ttm)	455.68M
Net Income (ttm)	39.97M
Shares Out	n/a
EPS (ttm)	3.38
PE Ratio	17.92
Forward PE	n/a
Dividend	0.72 (0.99%)
Ex-Dividend Date	Jun 4, 2024

Volume	101
Average Volume	126
Open	73.30
Previous Close	72.30
Day's Range	73.30 - 73.30
52-Week Range	73.30 - 108.99
Beta	0.90
RSI	54.80
Earnings Date	Mar 20, 2025

About Vetoquinol

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1933
• Employees: 2,440
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O1O

Financial Performance

In 2023, Vetoquinol's revenue was 529.27 million, a decrease of -1.95% compared to the previous year's 539.78 million. Earnings were 55.56 million, an increase of 15.76%.

Financial numbers in EUR